Risk factors associated with antineoplastic chemotherapy-induced nausea and vomiting

OBJECTIVE: To estimate the incidence and to evaluate risk factors for antineoplastic nausea and vomiting with high and moderate emetogenic chemotherapy in adult patients in the first treatment cycle. METHODS: Prospective cohort study with follow-up of 269 adults during the first cycle of antineoplas...

Descripción completa

Detalles Bibliográficos
Autores principales: Simino, Giovana Paula Rezende, Reis, Ilka Afonso, Acurcio, Francisco de Assis, Andrade, Eli Iola Gurgel, Brazil, Natalia Maria Linhares, Cherchiglia, Mariângela Leal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade de Saúde Pública da Universidade de São Paulo 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647467/
https://www.ncbi.nlm.nih.gov/pubmed/33175025
http://dx.doi.org/10.11606/s1518-8787.2020054002178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647467/
https://www.ncbi.nlm.nih.gov/pubmed/33175025
http://dx.doi.org/10.11606/s1518-8787.2020054002178

Ejemplares similares